OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Physiology-Cell Physiology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Sulforaphane attenuates cancer cell-induced atrophy of C2C12 myotubes	311
Normal muscle fiber type distribution is recapitulated in aged ephrin-A3^−/− mice that previously lacked most slow myofibers	125
A rapid degradation of calponin 2 is required for cytokinesis	109
Microbiota protect against frailty and loss of skeletal muscle, and maintain inflammatory tone during aging in mice	105
Lasmiditan induces mitochondrial biogenesis in primary mouse renal peritubular endothelial cells and augments wound healing and tubular network formation	81
Biological sex divergence in transcriptomic profiles during the onset of hindlimb unloading-induced atrophy	77
Are you listening: cellular signaling in ECM-driven diseases	72
Resistance exercise and mechanical overload upregulate vimentin for skeletal muscle remodeling	68
Following Ussing’s legacy: from amphibian models to mammalian kidney and brain	67
EphrinB2 drives osteogenic fate of adult cardiac fibroblasts in a calcium influx dependent manner	66
Mitochondrial antioxidant SkQ1 attenuates C26 cancer-induced muscle wasting in males and improves muscle contractility in female tumor-bearing mice	65
Role of myofiber-specific FoxP1 in pancreatic cancer-induced muscle wasting	62
Chloride transport modulators as drug candidates	60
TRPV4 and chloride channels mediate volume sensing in trabecular meshwork cells	57
MALDI-MSI Reveals Shared Lipid Signatures in Sarcoid-Like Granulomas of Mice and in a Human Case	54
Differential MMP-14 targeting by biglycan, decorin, fibromodulin, and lumican unraveled by in silico approach	53
Immune system activation and cognitive impairment in arterial hypertension	53
Proteolysis: a key post-translational modification regulating proteoglycans	52
Microscopic computed tomography with AI-CNN-powered image analysis: the path to phenotype bleomycin-induced lung injury	52
Regulation of the intestinal Na⁺/H⁺ exchanger NHE3 by AMP-activated kinase is dependent on phosphorylation of NHE3 at S555 and S563	51
Hydrogen sulfide in health and diseases: cross talk with noncoding RNAs	50
Inhibition of mitochondrial citrate shuttle alleviates metabolic syndromes induced by high-fat diet	49
TRPV1 enhances cholecystokinin signaling in primary vagal afferent neurons and mediates the central effects on spontaneous glutamate release in the NTS	46
Small molecule drugs to improve sarcomere function in those with acquired and inherited myopathies	44
Syndecan-1 in liver pathophysiology	41

Enteroendocrine cells regulate intestinal barrier permeability	41
Inhibition of mitochondrial fission protein Drp1 ameliorates skeletal myopathy in the D2-mdx model of Duchenne muscular dystrophy	40
The European and Japanese eel NaCl cotransporters β exhibit chloride currents and are resistant to thiazide type diuretics	40
miR-19b-3p is associated with a diametric response to resistance exercise in older adults and regulates skeletal muscle anabolism via PTEN inhibition	40
Proteoglycans: a common portal for SARS-CoV-2 and extracellular vesicle uptake	39
Effect of the mitochondrial transaminase (GOT2) on membrane potential-sensitive respiration in mitochondria of differentiated C2C12 muscle cells	39
The HIF2α-dependent upregulation of SETDB1 facilitates hypoxia-induced functional and phenotypical changes of pulmonary microvascular endothelial cells	39
Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle	39
Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells	38
Parkin-mediated mitophagy is a potential treatment for oxaliplatin-induced peripheral neuropathy	38
G-protein tonic inhibition of calcium channels in pancreatic β-cells	37
ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells	36
Corrigendum for Tuncay et al., volume 324, 2023, p. C1017–C1027	36